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in right ventricular apex, the ICD was placed in the left chest.
RESULTS All patients were successfully implanted ICD. We gave
those Postoperatives a follow-up of 3 w 12 months, no surgery related
complications happened. Among of them, there were 2 patients
launched the ICD therapy program (electric shock cardioverter, deﬁ-
brillation or ATP treatment), and the other 2 cases did not start
treatment program.
CONCLUSIONS The ICD can convert the malignant arrhythmia effec-
tively, it is a preferred treatment in the treatment of malignant
arrhythmia, and the prevention of sudden death.
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To evaluate the relational ships between heart rate changes before and
after pacemaker implantation and BNP
Shuangbin Li
Jilin City Central Hospital
OBJECTIVES To evaluate the relational ships between heart rate
changes before and after pacemaker implantation and B-type brain
natriuretic peptide (BNP) levels.
METHODS A total of 118 patients with sick sinus syndrome of DDD(R)
cardiac pacemaker therapy and 100 patients with atrial ﬁbrillation and
slow heart rate of single cavity (VVI) cardiac pacemaker therapy from
December 2007 to January 2011 were enrolled in this study. We fol-
lowed the changes of heart rate for postoperative patients and detect
the plasma BNP level with enzyme-linked immunosorbent method;
we get the change rules between the two by comparison.
RESULTS Through a median follow-up of 60 days and laboratory tests
and pacemaker programmed control, Compared with preoperative
plasma levels, the plasma BNP levels of the sick sinus syndrome who
Accept double cavity of DDD cardiac pacemaker therapy (R) declined
signiﬁcantly[ (272.1721.23) ng/L vs (52.3918.22) ng/L, P<0.01]. Atrial
ﬁbrillation with slow heart rate who accepted single cavity VVI cardiac
pacemaker therapy [(112.0311.34) ng/L vs. (103.9312.54) ng/L,
P<0.01], Compared with preoperative plasma levels, blood plasma
BNP level has no obvious changes. The relationship between heart
rate and blood plasma BNP levels were signiﬁcantly.
CONCLUSIONS Slow heart rate can increase left cardiac preload and
damage ventricular systolic function and cause cardiac insufﬁciency
for a long time.ARRHYTHMIA INTERVENTION
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Warfarin Effect on Renal function in Patients with Nonvalvular Atrial
Fibrillation: Results from the Chinese Atrial Fibrillation Registry
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OBJECTIVES Warfarin is the most commonly used oral medication for
anticoagulation to reduce the risk of stroke from atrial ﬁbrillation, but
little data is available for demonstrating its impacts on renal function
of patients with nonvalvular atrial ﬁbrillation (NVAF).
The prospective study aimed to evaluate warfarin effect on renal
function by analyzing data of a total of 1590 Chinese adult patients,
enrolled in the Chinese Atrial Fibrillation Registry, with ECG-detected
NVAF with no dialysis.
METHODS We calculated estimated glomerular ﬁltration rate (eGFR)
using the Chinese Modiﬁcation of Diet in Renal Disease study equa-
tion. Patients were divided into two groups, one group with warfarin
(n¼ 696) and the other group with no anticoagulation (n¼894 ). The
endpoint was reached with the event of a S 25% decrease in eGFR.
The results of laboratory investigations and eGFR were recorded at
months 3, 6, 12, 18, and 24 from treatment initiation.
RESULTS With follow-up over 2.7 years, comparing the two groups,
warfarin grouphas less event rate thanno anticoagulation group (8.05%
versus 12.08%, p¼0.005) and longer survival time (LogRank p¼0.020).
Additionally, in our multivariate Cox regression analysis, warfarin
therapy was discovered to be the only protective factor in these NVAF
patients (Hazard Rate 0.700 ,95% CI: 0.496-0.990, P ¼ 0.044).
CONCLUSIONS Warfarin therapy has protection effect on event of a
S25% decrease in eGFR and delays kidney function deterioration in
Chinese patients with NVAF.GW26-e1465
Self management of warfarin therapy in atrial ﬁbrillation patients in China,
a pilot study
Fan Wu, Ping Lei
Tianjin Medical University General Hospital
OBJECTIVES The objective of this study was to evaluate the impact of
a patient self-management program on security, efﬁcacy, quality of
life about anticoagulation control in AF patients requiring chronic
warfarin therapy compared with clinic standard treatment in China.
METHODS Our study was a prospective cohort study. 274 eligible sub-
jects agreed to participate. 89 subjects chose the portable INR monitor
to self-testing at home, who were assigned to PSM group. 185 subjects
received standard treatment in an anticoagulation clinic, they were
assigned to conventional group. the PSM group participated in the
consecutive instruction courses that aimed to practice OAC manage-
ment on their own. Follow-up 12 months. Quality of life (QOL) was
assessed using the questionnaire Short-Form 12 Health Survey, version
2 (SF-12v2), Time in therapeutic range (TTR) assessed the quality of the
anticoagulation treatment given. An INR range of 2.0 to 3.0 has been
established as therapeutic by stroke prevention trials in AF.
RESULTS 80 subjects in PSM group and 168 subjects in conventional
group completed the study, respectively. The two groups of data are
shown that the regression equation for measured value of the portable
INR monitor (y axis) and traditional central lab measured value (x
axis) is y ¼ 0.927x þ0.177. Good correlation between the INR
measured values of the two groups can be observed (r ¼ 0.926, p <
0.05). Meanwhile, its bias can be observed with Bland-Altman dia-
gram, the bias between the Self-testing INR and the conventional
method INR in parallel is (0.173  0.157) and no sample bias more
than 0.5 INR units. The median frequency of INR measurements in the
study period was 7.3 days test INR one time in PSM group compared to
38.7 days in the conventional group ( p¼0.000). Medians of the per-
centage of TTR was 68% versus 57% (p¼0.000). Cumulative risk of the
ﬁrst primary endpoint is performed by using Kaplan-Meier analysis,
P¼0.131. Thromboembolic complications occurred in 4 patients in the
PSM group versus in 15 patients in the conventional group( P¼0.277).
major bleeding events occurred in 1 patients versus 6 patients in the
PSM group and the conventional group, respectively( P¼0.534). At
least one minor bleeding occurred in two groups was no statistically
signiﬁcant ( P¼0.465). There were signiﬁcant improvement ( P¼0.038)
of the total physical score between the PSM group (42.3 5.3) and
control group (40.75.8) after 12months follow-up. Signiﬁcant
improvement was also observed in total mental composite score
(P¼0.046) in the PSM group(53.46.5) compared to control(51.5 7.2 ).
CONCLUSIONS Patient self-testing of INR has a good consistency and
stability compared with traditional laboratory testing. For the AF pa-
tients requiring chronic warfarin therapy compared with standard
treatment, the patient self-management of anticoagulation therapy is
a security and efﬁcacious choice, which could improve AF patient’s
quality of life and has a promising future application in China.
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Are 23-mm Cryoballoons Better than 28-mm Ones for the Treatment of
Atrial Fibrillation in China?
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OBJECTIVES To compare the procedural parameters, safety and ef-
ﬁcacy between the two sizes (23- and 28- mm) of the ﬁrst-generation
cryoballoon catheter for the treatment of atrial ﬁbrillation in China.
METHODS Eighty - one consecutive patients with drug-refractory,
symptomatic AF (96.3% paroxysmal) underwent pulmonary vein
isolation (PVI) with the ﬁrst-generation CBC were enrolled. Two
groups were deﬁned according to the balloon used during each pro-
cedure: Group 23- and 28- mm. The procedural parameters, proce-
dure-related complications, acute and mid-term success rates were
compared between the two groups.
RESULTS The percentage of procedures with 23-, 28- mm balloon
alone, and double balloons was 49.4%, 46.9% and 3.7%. Compared
with Group 28- mm, the mean freeze time (41.6  9.7 vs. 32.9  3.5
min, P < 0.001), ﬂuoroscopic time (46.2  15.3 vs. 33.9  10.9 min, P <
0.001) and procedural time (125.0  27.2 vs. 98.3  18.2 min, P < 0.001)
was shorter in Group 23- mm, the acute PVI rate with CBC alone was
higher both on vein level (90.7% vs. 96.9%, P ¼ 0.021) and patient
